BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

Cleantech: Burst bubble or our biggest opportunity?
Opinion

Peter Griffin: Cleantech: Burst bubble or our biggest opportunity?

A thriving cleantech sector could be NZ’s ticket to a sustainable, high-value economy.

Why luxury needs a wake-up call
Opinion Fashion

Eden Bradfield: Why luxury needs a wake-up call

The focus should be on selling consumers a lifestyle, not just status symbols. 

Eden Bradfield 01 Jul 2025
Facebook is no place for risky financial investment offers
Opinion

Maria Slade: Facebook is no place for risky financial investment offers

Misleading ads continue to be thrust in the faces of Mum and Dad investors.

Maria Slade 30 Jun 2025